LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Dye Checks Heparin Levels in Blood

By LabMedica International staff writers
Posted on 26 Feb 2013
Print article
Scientists have developed a dye that provides a quick and accurate method of checking heparin levels in the blood. The modified dye, which has excellent sensing capacity for heparin, pinpoints the anticoagulant's level in human serum and has the potential to work more quickly than existing clinical methods for doing this.

Because the dye can rapidly detect heparin levels, the scientists have named it “Mallard Blue,” (the same shade as the livery of the A4 Pacific Mallard, which holds the world speed record for a steam locomotive).

Heparin is an important anticoagulant, which has a significant role in major surgery. The scientists in the department of chemistry at York University (Toronto, Canada) studied biological systems to discover how the dye would bind heparin even in highly competitive human serum.

In the laboratory, the scientists modified existing dyes, which previously could not bind with heparin successfully under these challenging conditions. The scientists in the department of chemistry at York used inspiration from biological systems to allow the dye to bind heparin even in the highly competitive human serum. The modified dye, which has excellent sensing capacity for heparin pinpoints the anticoagulant’s level in human serum and has the potential to work more quickly than existing clinical methods for doing this. The work was published in the online edition of February 13, 2013, Journal of the American Chemical Society.

The York scientists worked with a team led by Sabrina Pricl at the University of Trieste (Italy), who used high-level computer modeling to understand precisely how Mallard Blue binds to heparin so strongly.

The next stage in this work will involve the incorporation of this new dye into a device for simple bedside read-out of heparin levels in blood.

Related Links:

York University
University of Trieste


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more